We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: Using blood samples and physical measures from children as young as 8, investigators identified protein signatures that mirrored adult biomarkers linked to irreversible cardiovascular disease (Image Credit: Shutterstock)

Childhood Blood Biomarkers May Reveal Early Heart, Kidney, and Metabolic Risks

An AI-derived blood proteomic signature flags early cardio-kidney-metabolic risk in children, enabling targeted prevention. More...
15 Sep 2026
Image Credit: Adobe Stock

Blood-Based DNA Analysis Method Detects Early-Stage Solid Cancers

A new liquid biopsy detects stage I/II solid cancers from plasma ctDNA with 95% early-stage sensitivity. More...
15 Sep 2026
Image: Graphical Abstract (Zeyang Shen et al., Shotgun Metagenomics Reveals Skin Microbiome Composition and Function in Infant Atopic Disease, Allergy, 2026. DOI: 10.1111/all.70449)

Infant Skin Microbiome Show Links to Later Eczema and Food Allergies

New findings show microbial patterns on infant skin are associated with later eczema and food allergy outcomes More...
15 Sep 2026
Image: The Lumipulse G NfL Blood assay provides a reliable method for the quantitative measurement of neurofilament light chain NfL in serum and plasma (Photo courtesy of Fujirebio)

Blood-Based Neurology Biomarker Assays Authorized for Use in Brazil

Fujirebio received ANVISA authorization in Brazil for its Lumipulse G NfL Blood and pTau 217 Plasma assays on the LUMIPULSE G platform. More...
14 Sep 2026
Image: Researchers found that combining two Alzheimer’s tests—a p-tau217 blood test and APOE genotyping—can predict symptom onset in people who are not yet experiencing symptoms (Image Credit: Adobe Stock)

Combined Blood and Genetic Tests Estimate Timing of Alzheimer’s Symptom Onset

A combined blood-based Alzheimer’s marker and genetic risk test estimates time to symptom onset within 3–6 years in asymptomatic adults. More...
14 Sep 2026
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

New findings outline multimodal AI integration to improve immunotherapy selection and toxicity prediction. More...
14 Sep 2026
Image Credit: Adobe Stock

Diagnostic Stewardship Guide Targets Testing Overuse and Hospital Cost Pressures

A new guide outlines business cases for diagnostic stewardship to align test use, improve quality metrics, and cut costs. More...
14 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Next-Generation Sequencing Platform
AXELIOS 1 Platform
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Copyright © 2000-2026 Globetech Media. All rights reserved.